These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7866982)

  • 1. Loss of the metastatic phenotype in murine carcinoma cells expressing an antisense RNA to the insulin-like growth factor receptor.
    Long L; Rubin R; Baserga R; Brodt P
    Cancer Res; 1995 Mar; 55(5):1006-9. PubMed ID: 7866982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of hamster mesothelioma tumorigenesis by an antisense expression plasmid to the insulin-like growth factor-1 receptor.
    Pass HI; Mew DJ; Carbone M; Matthews WA; Donington JS; Baserga R; Walker CL; Resnicoff M; Steinberg SM
    Cancer Res; 1996 Sep; 56(17):4044-8. PubMed ID: 8752177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced invasion and liver colonization by lung carcinoma cells overexpressing the type 1 insulin-like growth factor receptor.
    Long L; Rubin R; Brodt P
    Exp Cell Res; 1998 Jan; 238(1):116-21. PubMed ID: 9457063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of human breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor inhibits cell growth, suppresses tumorigenesis, alters the metastatic potential, and prolongs survival in vivo.
    Chernicky CL; Yi L; Tan H; Gan SU; Ilan J
    Cancer Gene Ther; 2000 Mar; 7(3):384-95. PubMed ID: 10766344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The insulin-like growth factor 1 receptor induces transformation and tumorigenicity of ovarian mesothelial cells and down-regulates their Fas-receptor expression.
    Coppola D; Saunders B; Fu L; Mao W; Nicosia SV
    Cancer Res; 1999 Jul; 59(13):3264-70. PubMed ID: 10397275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth regulation of human glioblastoma T98G cells by insulin-like growth factor-1 and its receptor.
    Ambrose D; Resnicoff M; Coppola D; Sell C; Miura M; Jameson S; Baserga R; Rubin R
    J Cell Physiol; 1994 Apr; 159(1):92-100. PubMed ID: 8138595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant expression and activation of insulin-like growth factor-1 receptor (IGF-1R) are mediated by an induction of IGF-1R promoter activity and stabilization of IGF-1R mRNA and contributes to growth factor independence and increased survival of the pancreatic cancer cell line MIA PaCa-2.
    Nair PN; De Armond DT; Adamo ML; Strodel WE; Freeman JW
    Oncogene; 2001 Dec; 20(57):8203-14. PubMed ID: 11781836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paracrine growth stimulation by hepatocyte-derived insulin-like growth factor-1: a regulatory mechanism for carcinoma cells metastatic to the liver.
    Long L; Nip J; Brodt P
    Cancer Res; 1994 Jul; 54(14):3732-7. PubMed ID: 7518344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of tumorigenicity and metastatic potential in carcinoma cells expressing the extracellular domain of the type 1 insulin-like growth factor receptor.
    Samani AA; Chevet E; Fallavollita L; Galipeau J; Brodt P
    Cancer Res; 2004 May; 64(10):3380-5. PubMed ID: 15150088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the Mr 72,000 type IV collagenase by the type I insulin-like growth factor receptor.
    Long L; Navab R; Brodt P
    Cancer Res; 1998 Aug; 58(15):3243-7. PubMed ID: 9699649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of the insulin-like growth factor I receptor by antisense RNA can reverse the transformed phenotype of human cervical cancer cell lines.
    Nakamura K; Hongo A; Kodama J; Miyagi Y; Yoshinouchi M; Kudo T
    Cancer Res; 2000 Feb; 60(3):760-5. PubMed ID: 10676665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor.
    Resnicoff M; Coppola D; Sell C; Rubin R; Ferrone S; Baserga R
    Cancer Res; 1994 Sep; 54(18):4848-50. PubMed ID: 8069850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effects of an adenovirus expressing antisense insulin-like growth factor I receptor on human lung cancer cell lines.
    Lee CT; Wu S; Gabrilovich D; Chen H; Nadaf-Rahrov S; Ciernik IF; Carbone DP
    Cancer Res; 1996 Jul; 56(13):3038-41. PubMed ID: 8674059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines.
    Jackson JG; Zhang X; Yoneda T; Yee D
    Oncogene; 2001 Nov; 20(50):7318-25. PubMed ID: 11704861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of an antisense expression plasmid to the IGF-1 receptor on hamster mesothelioma proliferation.
    Pass HI; Mew DJ; Carbone M; Donington JS; Baserga R; Steinberg SM
    Dev Biol Stand; 1998; 94():321-8. PubMed ID: 9776253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The secretory leukocyte protease inhibitor is a type 1 insulin-like growth factor receptor-regulated protein that protects against liver metastasis by attenuating the host proinflammatory response.
    Wang N; Thuraisingam T; Fallavollita L; Ding A; Radzioch D; Brodt P
    Cancer Res; 2006 Mar; 66(6):3062-70. PubMed ID: 16540655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
    Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV
    Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of responsiveness to IGF-I in cells with reduced cathepsin L expression levels.
    Navab R; Pedraza C; Fallavollita L; Wang N; Chevet E; Auguste P; Jenna S; You Z; Bikfalvi A; Hu J; O'Connor R; Erickson A; Mort JS; Brodt P
    Oncogene; 2008 Aug; 27(37):4973-85. PubMed ID: 18469859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
    Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.